Cargando…

Change of genitourinary cancer patients’ perception and expectations over the course of pharmacotherapy

To determine the course of treatment while considering the patients’ desires, we examined trends regarding patients’ perception and expectations over the course of cancer pharmacotherapy. We retrospectively reviewed interview sheets filled in by patients with advanced urogenital cancers when they st...

Descripción completa

Detalles Bibliográficos
Autores principales: Satou, Yoshiaki, Ieiri, Kousuke, Negishi, Takahito, Furubayashi, Nobuki, Nakamura, Motonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681061/
https://www.ncbi.nlm.nih.gov/pubmed/36413565
http://dx.doi.org/10.1371/journal.pone.0278039
Descripción
Sumario:To determine the course of treatment while considering the patients’ desires, we examined trends regarding patients’ perception and expectations over the course of cancer pharmacotherapy. We retrospectively reviewed interview sheets filled in by patients with advanced urogenital cancers when they started a new pharmacotherapy regimen between 2014 and 2020. The responses to the following questions were analyzed: 1) How did your doctor explain the treatment objectives?; 2) Are you willing to receive treatment?; and 3) When the standard treatment becomes difficult to continue, would you like to try another treatment even if it may cause severe side effects? A total of 277 patients answered the interview sheet. The percentage of patients who accurately perceived the treatment objectives among patients receiving 1(st), 2(nd), and 3(rd) line regimens was 67%, 79%, and 93%, respectively. The percentage significantly improved over the course of pharmacotherapy (p = 0.0057). The percentage of patients who indicated that they were willing to receive treatment in 1(st), 2(nd), and 3(rd) line regimens was 80%, 83%, and 86%, respectively. The percentage of patients who indicated that they wanted to try another treatment when the standard treatment became difficult to continue in 1(st), 2(nd), and 3(rd) line regimens was 56%, 64%, and 59%, respectively. The percentage of patients who accurately perceived the objective of pharmacotherapy increased over the course of pharmacotherapy. The rate of patients who were willing to receive treatment and try other treatments when the standard treatment became too difficult to continue remained consistently high.